TrialAnnals of oncology : official journal of the European Society for Medical Oncology2013

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

R J Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.